References
- Kulczycki L L, Butler J S, McCord-Dickman D, Herer GR. The hearing of patients -with cystic fibrosis. Arch Otolaryngol 1970; 92: 54–9
- Lorin M I, Dennin C R, Mandel ID. Viscosity of excrine secretions in cystic fibrosis: sweat, duodenal fluid, and submaxillary saliva. Biorheology 1972; 9: 27–32
- Slavit D H, Kasperbauer JL. Ciliary dysfunction syndrome and cystic fibrosis. Systemic disease and the nasal airway., TV McCaffrey. Thieme Medical Publishers, New York 1993; 131–9
- Cromwell O, Morris H R, Walport M J, Taylor GW. Indentification of leukotrienes D and B in sputum from cystic fibrosis patients. Lancet 1981; ii: 164–5
- Leiberman A, Cole P, Corey M, Forte V, Levison H. Otolaryngological and rhinomanometric findings in cystic fibrosis. Am J Rhinol 1991; 5: 61–5
- Brihaye P. Clement P, Dab I, Desprechin B. Pathological changes of the lateral wall in patients with cystic fibrosis (mucoviscidosis). Int J Pediatr Otorhinolaryn-gol 1994; 28: 141–7
- Gibson L E, Cooke RE. A test for concentration of the electrolytes in sweat in Cystic Fibrosis utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23: 545–9
- Wang D Y, Clement P, Smitz J, De Waele M, Derde M-P. Correlations between complaints, inflammatory cells and mediators after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995; 106: 278–81
- Biewenga J, Stoop A E, Baker H E, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem 1991; 28: 260–6
- Knani J, Campbell A, Enander I, Peterson C GB, Michel F-B, Bousquet J. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol 1992; 90: 881–9
- Sørensen H. Rhinologic aspects of cystic fibrosis. Pediatric otorhinolaryngology., B Jazbi. Appleton-Century-Crofts, New York 1980; 117–26
- Marker CW. Neutrophil mechanisms. Am Rev Respir Dis 1991; 143: S59–60
- Venge P, Strömberg A, Braconier J H, Roxin L E, Olsson I. Neutrophil and eosinophil granulocytes in bacterial infection. Sequential studies of cellular and serum levels of granule proteins. Br J Haematol 1978; 38: 475–83
- Frigas E, Gleich GJ. The eosinophil and pathophysiology of asthma. J Allergy Clin Immunol 1986; 77: 527–37
- Well P R, Lee C W, Foster D W, Corey E J, Austen K F, Lewis RB. Generation and metabolism of 5-lipoxyge-nase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci USA 1983; 80: 7626–30
- Langer HM. Allergic rhinitis: a medical insight. J Otolaryngol 1989; 18: 158–64
- Venge P. Eosinophil and neutrophil granulocytes. Allergy 1993; 48: 39–47
- Jordana M, Dolovich J, Ohno I, Finotto S, Denburg J. Nasal polyposis: a model for chronic inflammation. Asthma and rhinitis., W W Busse, ST Holgate. Black well Scientific Publications, Boston 1995; 156–64
- Koller D Y, Gotz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994; 49: 496–9
- Carlson M, Hakansson L, Peterson C, Stalenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991; 87: 27–33
- Wang D Y, Clement P, Smitz J, Derde M-P. Concentrations of chemical mediators in nasal secretions of patients with hay fever during natural allergen exposure. Acta Otolarynol (Stockh) 1994; 114: 552–5
- Proud D, Bailey G S, Naclerio R M, et al. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol 1992; 89: 1098–10
- Kulczycki L L, Mueller H, Shwachman H. Respiratory allergy in patients with cystic fibrosis. JAMA 1961; 4: 104–10